ethambutol
Showing 1 - 25 of 35
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto
Recruiting
- Nontuberculous Mycobacterial Lung Disease
- Nontuberculous Mycobacterium Infection
- Hypertonic saline
- +3 more
-
New York, New York
- +2 more
Jan 27, 2023
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)
Recruiting
- Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Bedaquiline
- +4 more
-
Aichi, Japan
- +42 more
Jan 17, 2023
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022
Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)
Recruiting
- Tuberculosis
- +2 more
- Isoniazid
- +4 more
-
Johannesburg, Gauteng, South AfricaTembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022
Lung Infection, Mycobacterium Avium Complex Trial in Amiens, Marseille (Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin)
Recruiting
- Lung Infection
- Mycobacterium Avium Complex
- Clarithromycin 1000 MG
- +3 more
-
Amiens, Picardie, France
- +1 more
Aug 23, 2021
Four Months Moxifloxacin Containing Daily Regimen Study Among
Not yet recruiting
- Tuberculosis, Pulmonary
- Isoniazid
- +4 more
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Sep 29, 2021
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,
Recruiting
- Mycobacterium Avium Complex
- Nontuberculous Mycobacterium Infection
- Azithromycin
- +2 more
-
Loma Linda, California
- +26 more
Jan 18, 2023
Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)
Completed
- Cystic Fibrosis
- Ethambutol
- +3 more
-
Aurora, ColoradoChildren's Hospital Colroado
Jan 20, 2021
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Sarcoidosis; Antimycobacterial Therapy Trial in United States (Levofloxacin, Ethambutol, Azithromycin)
Completed
- Sarcoidosis; Antimycobacterial Therapy
- Levofloxacin
- +4 more
-
Albany, New York
- +5 more
Jul 7, 2020
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Active, not recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +110 more
Jan 23, 2023
Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- High-dose rifampicin
- +4 more
-
Seoul, Korea, Republic ofDivision of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020
Uveitis, Anterior Trial (Antitubercular treatment (RIFATER ©), Ethambutol, RIFINAH ©)
Not yet recruiting
- Uveitis, Anterior
- Antitubercular treatment (RIFATER ©)
- +2 more
- (no location specified)
Oct 4, 2019
Antiretroviral Drugs and Related Drugs During and After
Tuberculosis Trial in Vitória, Makati, Kampala (Ethambutol, Isoniazid, Pyrazinamide)
Completed
- Tuberculosis
- Ethambutol
- +3 more
-
Vitória, Espírito Santo, Brazil
- +2 more
Oct 11, 2018